36339 - Everolimus (Answered)

Greg Mulholland
To ask the Secretary of State for Health, pursuant to the Answer of 15 March 2016 to Question 29900, on tuberous sclerosis, for what reasons the policy statement for the commissioning of Everolimus for treating angiomyolipomas has not yet been published; and when he plans to publish that statement.

George Freeman

The policy statement for the commissioning of Everolimus for treating angiomyolipomas has not yet been published owing to delays experienced when incorporating the needs of children into the policy.

Those issues have now been resolved and the policy is due to be published imminently on NHS England’s website.